AkzoNobel launches a US dollar bond issue ahead of its merger with Axalta
In a press release published on 17 November 2026, AkzoNobel announced a bond issue whose proceeds could also be used to refinance Axalta's debt, once their all-share merger of equals is completed.
The transaction is not conditional on this combination, but it includes a mandatory redemption clause if the merger does not go ahead.
A privately placed notes issue guaranteed by AkzoNobel, open to refinancing Axalta's debt
The issue is carried out by Akzo Nobel, Inc., a wholly owned direct subsidiary of AkzoNobel, in the form of a private placement of senior U.S. dollar-denominated notes. These securities will benefit from a full and unconditional guarantee from the parent company, unsecured, and will rank pari passu with its other senior obligations.
The amount, timing and final terms of the offering will depend on market conditions and other factors, and the group states that there is no assurance the transaction will be completed.
The net proceeds are intended for general corporate purposes. They may also be used, in whole or in part, to refinance, after the merger, Axalta's term loans maturing on 20 December 2029.
Three outstanding Axalta bond series are also targeted: US$500 million due 2027, US$700 million due 2029 and US$500 million due 2031.
Mandatory redemption if the merger fails by November 2027
The merger is expected to close after the completion of the issue. If it is not completed by 18 November 2027 at 11:59 p.m., Central European Time, or at a later date provided for in the merger agreement, the issuer will be required to redeem all outstanding securities.
The same mechanism would apply if this agreement, signed with Axalta on 18 November 2025 and amended on 27 May and 23 July 2026, were terminated, or if AkzoNobel were to abandon the merger. On 6 November 2026, the European Commission had granted conditional approval of the transaction, subject to the divestment of a business in Europe.
The securities, which have not been registered under the U.S. Securities Act of 1933, are offered only to qualified institutional buyers pursuant to Rule 144A and, outside the United States, under Regulation S.
A registration rights agreement, to be entered into at the time of the issue, will commit the issuer and AkzoNobel to use reasonable efforts to file with the SEC an exchange offer for new registered securities with substantially identical terms.